Duloxetine HCL DR Capsules
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D2-25-R-0010
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain is soliciting proposals for Duloxetine HCL DR Capsules through solicitation SPE2D2-25-R-0010. The procurement covers eight line items for capsules in multiple dosage strengths (20mg, 30mg, 40mg, and 60mg) and various bottle sizes (30, 60, 90, and 1000 count) to serve the Department of Defense, Veterans Affairs, Bureau of Prisons, and Indian Health Service. Contractors must provide FDA-approved products that demonstrate therapeutic equivalence, comply with current Good Manufacturing Practices, and are compatible with automated dispensing units such as Baxter ATC Canisters and OptiFill. The acquisition will utilize lowest price technically acceptable (LPTA) evaluation criteria and requires comprehensive documentation including manufacturing facility details, past performance information, and detailed pricing data. The proposal submission deadline has been extended multiple times and is currently set for September 5, 2025, at 3:00 PM EST, with proposals required to be submitted electronically through the Defense Logistics Agency Internet Bid Board System (DIBBS).
This solicitation does not include any set-aside designations and no current incumbents or contractors are identified in the available documentation. The contract structure is a firm-fixed-price requirements contract for a one-year base period with four option years, not to exceed five years total, though specific award values are not disclosed. Estimated annual quantities vary significantly across line items, with the 30mg 90-count bottle representing the highest volume requirement at 155,424 bottles annually, while the 60mg 90-count bottle has the lowest estimated requirement at 4,161 bottles per year. Contract performance is scheduled to begin 45 calendar days after award, and the selected contractor will be required to provide quarterly sales reporting with a 0.5% cost recovery fee. The procurement will establish a national supply contract that supports pharmaceutical distribution through Prime Vendor contractors across multiple federal agencies.
Notice text
SPE2D2-25-R-0010 Duloxetine HCL DR Solicitation
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Duloxetine HCL DR Capsules | Award Notice | |
| This notice | Solicitation | |
| Duloxetine HCL DR Capsules | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity